Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech
Profusa received ISO 13485 certification from GMED, advancing its Lumee Oxygen Platform toward CE marking in the European Union.
Stocks · News reference
Profusa Receives Nasdaq Letter Indicating Compliance; Company Remains Subject To A One-Year Mandatory Panel Monitor
On September 9, 2026, the Company received a letter (the "Compliance Determination Letter") from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has demonstrated compliance with Nasdaq
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
U.S. stocks fell Thursday as tech slid; jobless claims beat estimates. Oil rose, while APUS surged 245% and BENF plunged 33%.
Profusa shares are trading higher after the company announced it received a positive decision from GMED regarding certification of its quality management system to ISO 13485.
Profusa Says It Received Positive Quality System Certification Decision From EU Certifier GMED; Lumee CE Mark Still Pending